A Study to Assess the Availability of Oral Primaquine and Its Inert Metabolite, Carboxyprimaquine, in the Body
Conditions:   Healthy;   Pharmacokinetic Interventions:   Drug: Regimen 1 (Oral primaquine);   Drug: Regimen 2 (IV primaquine phosphate);   Drug: Regimen 3 (IV carboxyprimaquine) Sponsors:   University of Oxford;   Mahidol Oxford Tropical Medicine Research Unit;   Faculty of Tropical Medicine, Mahidol University Bangkok, Thailand Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 10, 2023 Category: Research Source Type: clinical trials